Stevin Zorn, Ph.D., President and Chief Executive Officer, MindImmune Therapeutics, Inc.
Frank S. Menniti, Ph.D., Chief Science Officer, MindImmune Therapeutics, Inc.
Robert B. Nelson, Ph.D., Vice President, Exploratory Biology and Secretary, MindImmune Therapeutics, Inc.
Brian M Campbell, Ph.D., Vice President, Pharmacology and Treasurer, MindImmune Therapeutics, Inc.
Richard G. Horan, Senior Managing Director, Slater Technology Fund
Mario Saltarelli, M.D., Ph.D., Senior Vice President of Early Development, Vertex Pharmaceuticals, Inc., Boston, MA